Saving our next generation
Searching for early-detection genetic markers and treatment options for 20 to 39 year olds.
ePROMS-MEL project – Patient reported outcomes Stage III
Investigating including electronic Patient Reported Outcome Measures into routine care for Stage III melanoma patients.